248 related articles for article (PubMed ID: 25213373)
21. Oral lichen planus in patients infected or noninfected with hepatitis C virus: the role of autoimmunity.
Carrozzo M; Gandolfo S; Lodi G; Carbone M; Garzino-Demo P; Carbonero C; Porter SR; Scully C
J Oral Pathol Med; 1999 Jan; 28(1):16-9. PubMed ID: 9890452
[TBL] [Abstract][Full Text] [Related]
22. Oral symptoms and salivary findings in oral lichen planus, oral lichenoid lesions and stomatitis.
Larsen KR; Johansen JD; Reibel J; Zachariae C; Rosing K; Pedersen AML
BMC Oral Health; 2017 Jun; 17(1):103. PubMed ID: 28662707
[TBL] [Abstract][Full Text] [Related]
23. [Potentially malignant character of oral lichen planus and lichenoid lesions].
Mares S; Ben Slama L; Gruffaz F; Goudot P; Bertolus C
Rev Stomatol Chir Maxillofac Chir Orale; 2013 Nov; 114(5):293-8. PubMed ID: 23849797
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of antinuclear antibodies in 3 groups of healthy individuals: blood donors, hospital personnel, and relatives of patients with autoimmune diseases.
Marin GG; Cardiel MH; Cornejo H; Viveros ME
J Clin Rheumatol; 2009 Oct; 15(7):325-9. PubMed ID: 20009966
[TBL] [Abstract][Full Text] [Related]
25. The possible premalignant character of oral lichen planus and oral lichenoid lesions: a prospective five-year follow-up study of 192 patients.
van der Meij EH; Mast H; van der Waal I
Oral Oncol; 2007 Sep; 43(8):742-8. PubMed ID: 17112770
[TBL] [Abstract][Full Text] [Related]
26. Modulation of serum anti-thyroglobulin and anti-thyroid microsomal autoantibody levels by levamisole in patients with oral lichen planus.
Lin HP; Wang YP; Chia JS; Sun A
J Formos Med Assoc; 2011 Mar; 110(3):169-74. PubMed ID: 21497280
[TBL] [Abstract][Full Text] [Related]
27. Serum antinuclear antibody in adult Thais.
Prapinjumrune C; Prucktrakul C; Sooktonglarng T; Thongprasom K
Gerodontology; 2017 Mar; 34(1):86-89. PubMed ID: 27173106
[TBL] [Abstract][Full Text] [Related]
28. Oral lichen planus and lichenoid mucositis.
De Rossi SS; Ciarrocca K
Dent Clin North Am; 2014 Apr; 58(2):299-313. PubMed ID: 24655524
[TBL] [Abstract][Full Text] [Related]
29. A histochemical and immunohistochemical study of mast cells in differentiating oral lichen planus from oral lichenoid reactions.
Jahanshahi G; Aminzadeh A
Quintessence Int; 2010 Mar; 41(3):221-7. PubMed ID: 20213023
[TBL] [Abstract][Full Text] [Related]
30. The role of histopathological characteristics in distinguishing amalgam-associated oral lichenoid reactions and oral lichen planus.
Thornhill MH; Sankar V; Xu XJ; Barrett AW; High AS; Odell EW; Speight PM; Farthing PM
J Oral Pathol Med; 2006 Apr; 35(4):233-40. PubMed ID: 16519771
[TBL] [Abstract][Full Text] [Related]
31. Elevated serum levels of the apoptosis related molecules TNF-alpha, Fas/Apo-1 and Bcl-2 in oral lichen planus.
Sklavounou-Andrikopoulou A; Chrysomali E; Iakovou M; Garinis GA; Karameris A
J Oral Pathol Med; 2004 Aug; 33(7):386-90. PubMed ID: 15250829
[TBL] [Abstract][Full Text] [Related]
32. The ABO blood group antigens in patients with oral lichenoid reaction.
Panahian FG; Gholizadeh N; Sheykhbahaei N
Arch Dermatol Res; 2024 May; 316(5):185. PubMed ID: 38771380
[TBL] [Abstract][Full Text] [Related]
33. Immunomodulation by levamisole in patients with recurrent aphthous ulcers or oral lichen planus.
Sun A; Chiang CP; Chiou PS; Wang JT; Liu BY; Wu YC
J Oral Pathol Med; 1994 Apr; 23(4):172-7. PubMed ID: 7913970
[TBL] [Abstract][Full Text] [Related]
34. Anti-double stranded antibody. Association with titers and fluorescence patterns of anti-nuclear antibody in systemic lupus erythematosus.
Almogren A
Saudi Med J; 2010 Jan; 31(1):32-6. PubMed ID: 20062896
[TBL] [Abstract][Full Text] [Related]
35. Regression of oral lichenoid lesions after replacement of dental restorations.
Mårell L; Tillberg A; Widman L; Bergdahl J; Berglund A
J Oral Rehabil; 2014 May; 41(5):381-91. PubMed ID: 24843865
[TBL] [Abstract][Full Text] [Related]
36. Vulvovaginal-gingival Lichen Planus: Association with Lichen Planopilaris and Stratified Epithelium-specific Antinuclear Antibodies.
Olszewska M; Banka-Wrona A; Skrok A; Rakowska A; Górska R; Solomon LW; Rudnicka L
Acta Derm Venereol; 2016 Jan; 96(1):92-6. PubMed ID: 26014511
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of positive antinuclear antibodies in healthy children.
Wananukul S; Voramethkul W; Kaewopas Y; Hanvivatvong O
Asian Pac J Allergy Immunol; 2005; 23(2-3):153-7. PubMed ID: 16252846
[TBL] [Abstract][Full Text] [Related]
38. Oxidative stress factors and C-reactive protein in patients with oral lichen planus before and 2 weeks after treatment.
Hashemy SI; Gharaei S; Vasigh S; Kargozar S; Alirezaei B; Keyhani FJ; Amirchaghmaghi M
J Oral Pathol Med; 2016 Jan; 45(1):35-40. PubMed ID: 26058710
[TBL] [Abstract][Full Text] [Related]
39. Severity of oral lichen planus and oral lichenoid lesions is associated with anxiety.
Zucoloto ML; Shibakura MEW; Pavanin JV; Garcia FT; da Silva Santos PS; Maciel AP; de Barros Gallo C; Souza NV; Innocentini LMAR; Humberto JSM; Motta ACF
Clin Oral Investig; 2019 Dec; 23(12):4441-4448. PubMed ID: 30989337
[TBL] [Abstract][Full Text] [Related]
40. Immunological evaluation in oral lichen planus with chronic hepatitis C.
Nagao Y; Sata M; Abe K; Tanikawa K; Kameyama T
J Gastroenterol; 1997 Jun; 32(3):324-9. PubMed ID: 9213245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
